Author: healthadmin

The transfer of federal forest land in Arizona to two international companies planning to mine one of North America’s largest copper deposits has been completed, but a group of Apache women is asking the U.S. Supreme Court to intervene as a last resort to block the project. Title to the land was conveyed to Resolution Copper by the federal government on Friday after an appeals court denied a request by the San Carlos Apache Tribe and environmentalists to block the removal.The Court of Appeals reversed the appellate court’s decision, finding that the plaintiffs’ legal claims were unlikely to succeed. emergency…

Updated: March 16th 12:20pm ET The Trump Administration has launched grant applications for a new model aimed at providing Medicare coverage to functional medicine and lifestyle health care providers. The Centers for Medicare and Medicaid Services released “Make America Healthy Again: Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence (MAHA ELEVATE)” in December. Participants seeking grants under this model must submit a letter of intent by April 10th, with the final application deadline set for May 15th. In a funding notice issued March 13, the agency said it has selected 30 participants for the model and will receive a total…

In a clinical trial supported by the National Institutes of Health (NIH), researchers found that weekly injections of extended-release buprenorphine to treat opioid use disorder (OUD) during pregnancy resulted in higher rates of abstinence from illicit opioids than daily sublingual (sublingual) administration of buprenorphine, one of the standard treatments. Additionally, serious adverse events were less common in patients receiving extended-release therapy. Research findings support the use of this formulation of buprenorphine in the treatment of OUD during pregnancy. JAMA Internal Medicine. These findings are clinically valuable as they demonstrate that this injectable extended-release buprenorphine formulation can be safely used…

Type 2 diabetes (T2D) and obesity are metabolic diseases with many causes, including overlapping and distinct genetic features. Polygenic risk scores (PRS) capture multiple genetic risk factors and can estimate whether a person is likely to develop a complex medical condition and how they will cope in the long term. Researchers at Massachusetts General Brigham have built a metabolic PRS to predict obesity and T2D by integrating genetic findings from some of the world’s largest biobanks. It outperformed existing disease prediction models and predicted downstream morbidity and clinical interventions. The survey results are posted below cell metabolism. Our aim…

BioMarin is focused on its CNP analog, Voxzogo, to write the next chapter of the company’s growth story, but changes to its clinical development plan are adding further uncertainty to the company’s calculations. BioMarin will discontinue dosing and enrollment in its Phase 2 trial of Voxzogo, currently approved for achondroplasia, a form of dwarfism, in three potential indications: Turner syndrome, SHOX deficiency, and aggrecan (ACAN) deficiency. The move follows reports of “several” slipped femoral epiphysis (SCFE) events, in which the femoral head slips out of place, in two investigator-initiated trials of the drug, BioMarin said in a March 16 securities…

Extending the duration of monitoring for severe pregnancy complications shows that traditional delivery-focused monitoring misses more than 40% of cases, according to a new study published in . CMJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.251425 This extended monitoring from pregnancy to 6 weeks postpartum. Severe maternal morbidity (SMM) refers to complications during pregnancy that can cause death, prolonged hospitalization, or long-term disability. Current practice in Canada is to monitor and report cases of SMM during labor and delivery, but evidence suggests that extending the surveillance period from pregnancy to 6 weeks postpartum may be beneficial and consistent with World Health Organization…

Colorectal cancer remains one of the leading causes of cancer-related death worldwide, primarily due to metastasis and limited response to immunotherapy in most patients. Although immune checkpoint inhibitors have revolutionized the treatment of certain tumor subtypes, the majority of colorectal cancers remain ‘immune cold’, meaning they are unable to elicit effective antitumor immunity. Increasing evidence suggests that tumor-associated macrophages, particularly the M2 subtype, actively promote tumor growth, invasion, and immunosuppression. However, the molecular signals that drive macrophage polarization within colorectal tumors remain poorly understood. Therefore, understanding how tumor cells reshape immune behavior is essential to improve therapeutic outcomes. Based on…

New research published in natural mental health Higher rates of suicidal ideation and self-harm among older adults with autistic traits suggest that the traits themselves are not directly responsible. Rather, this increased risk appears to be driven by accompanying challenges such as depression, trauma, and social isolation. These findings provide evidence that targeted mental health support and promoting social connections may help protect this vulnerable population. If you or someone you know is experiencing suicidal thoughts or a mental health crisis, help is available. Contact the free and confidential Suicide & Crisis Lifeline by calling or texting 988 or live…

The White House’s direct-to-consumer (DTC) platform TrumpRx is steadily expanding its catalog, with the latest GSK and Amgen products joining the collection of medicines offered through the program. Amgen’s Humira biosimilar Amjevita, migraine drug Aimovig, and cholesterol drug Repatha became available through TrumpRx on Monday. Meanwhile, GSK is offering DTC discounts on some of its Ellipta inhalers and its influenza drug Relenza through its platform. Amjevita is available to cash-paying patients for $299 per month, an 80% discount from the physician’s list price of $1,484. According to the website, Aimovig and Repatha are discounted by 62% off their respective list…

With recent advances in drug discovery research, many drug candidate compounds with high therapeutic efficacy have been developed. However, many of these compounds have characteristics that make them difficult to handle, such as low water solubility and large molecular weights. As a result, it is poorly absorbed into the body, making it difficult to obtain sufficient therapeutic effects. Additionally, the drug is distributed into normal tissues, resulting in severe side effects. Fortunately, research is actively underway to develop drug delivery systems (DDS) that effectively solubilize these compounds and efficiently deliver them to cancer tissues. A research group led by Professor…